Internationally recognized cancer physician and scientist Dr. Daniel Von Hoff will give a seminar on new anti-cancer agent development at the College of Pharmacy March 27 at 3 p.m. in 201 Pharmacy South auditorium. The UGA community is invited to attend the reception that will follow.
His seminar, “New Anti-cancer Agent Development: The Dog Bit Off My Ear to the Thundergod Vine,” is sponsored by the UGA Cancer Center.
Von Hoff is a distinguished professor and physician-in-chief at the Translational Genomics Research Institute in Phoenix, Arizona.
Researchers from the UGA’s Complex Carbohydrate Research Center, including Michael Pierce, director of the UGA Cancer Center, Mike Tiemeyer and Lance Wells, are collaborating with Von Hoff and Caerus Therapeutics to identify cell surface glycans that can assist in early diagnosis of pancreatic cancer and monitoring of this cancer during its treatment.